This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chmelnitsky, I.
Right arrow Articles by Carmeli, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chmelnitsky, I.
Right arrow Articles by Carmeli, Y.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, August 2008, p. 2962-2965, Vol. 52, No. 8
0066-4804/08/$08.00+0     doi:10.1128/AAC.01341-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Plasmid-Mediated qnrB2 and Carbapenemase Gene blaKPC-2 Carried on the Same Plasmid in Carbapenem-Resistant Ciprofloxacin-Susceptible Enterobacter cloacae Isolates{triangledown}

Inna Chmelnitsky,1 Shiri Navon-Venezia,1 Jacob Strahilevitz,2 and Yehuda Carmeli1*

Division of Epidemiology, Tel-Aviv Medical Center, Tel Aviv, Israel,1 Department of Clinical Microbiology and Infectious Diseases, Hadassah-Hebrew University, Jerusalem2

Received 18 October 2007/ Returned for modification 3 January 2008/ Accepted 28 May 2008


arrow
ABSTRACT
 
Fourteen out of 16 carbapenem-resistant quinolone-susceptible Enterobacter cloacae isolates were found to carry qnrB2 and blaKPC-2 genes encoded on the same plasmid. One isolate also carried the aac(6')-Ib-cr gene. Coexistence of quinolone resistance determinants and blaKPC-2 on the same plasmid in quinolone-susceptible E. cloacae isolates may have important clinical implications.


arrow
TEXT
 
Quinolone resistance in gram-negative pathogens is commonly mediated by chromosomal mutations in DNA gyrase and topoisomerase IV by decreasing intracellular drug accumulation either due to decreased membrane permeability and/or due to chromosomally located efflux pumps (2, 21). In addition, quinolone resistance may be conferred by plasmid-mediated determinants, including the qnr genes qnrA, qnrB, and qnrS (4, 5, 7, 10), aac(6')-Ib-cr (18), and the recently identified transporter qepA (15, 26). The qnr gene products lead to increased MICs of quinolones, which in many cases are still below the CLSI breakpoints, and require the coexistence of an additional mechanism to lead to frank resistance. qnr genes may, however, facilitate selection of resistance-conferring chromosomal mutations (6, 10, 16, 20), and the penetration of qnr into the population of Klebsiella pneumoniae and Enterobacter spp. coincided with a rapid increase in fluoroquinolone resistance (23). qnr genes were found to be cocarried with various extended-spectrum or AmpC-type beta-lactamases on the same plasmid (6, 13, 17), as well as with metallo-beta-lactamase (25).

Recent carbapenem-resistant Enterobacter cloacae isolates from our hospital showed susceptibility to quinolones (9) according to the CLSI breakpoints (MIC ≤ 1 µg/ml). We aimed to describe the potential for emergence of quinolone resistance among these strains by determining the occurrence of the qnr and aac(6')-Ib-cr genes.

(This work was presented in part at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, 17 to 20 September 2007.)

Sixteen unique patient Enterobacter cloacae isolates, resistant to at least one carbapenem (imipenem, meropenem, or ertapenem), collected in Tel Aviv Medical Center, a 1,200-bed tertiary care teaching hospital between January 2004 and May 2006, were included in the study. Antibiotic susceptibilities were determined by Vitek-2 (bioMerieux Inc., Marcy l'Etoile, France). MICs of fluoroquinolones (ciprofloxacin [CIP] and levofloxacin [LEV]) and carbapenems were determined by Etest (AB Biodisk, Solna, Sweden), and MICs of nalidixic acid were determined by agar dilution. Genetic relatedness was analyzed by pulsed-field gel electrophoresis (PFGE). Bacterial DNA was cleaved with 20 U SpeI endonuclease (New England BioLabs) and electrophoresed in a CHEF-DR III apparatus (Bio-Rad Laboratories, Inc., Hercules, CA) (12, 22). DNA macrorestriction patterns were visually compared and interpreted (24). PCR using primers specific for blaKPC genes (3) and for blaSHV genes, (22) followed by sequencing was performed. Screening for qnrA, qnrB, and qnrS was carried out using multiplex PCR with primers described by Robicsek et al. (19). Bacterial cell lysates were used as DNA templates (22). Escherichia coli strain J53 carrying various plasmids, plasmids pMG252 (qnrA1), pMG298 (qnrB1), and pMG306 (qnrS1), were used as control strains. Amplification of the complete qnrB2 gene was performed with primer F (ATG GCT CTG GCA CTC GTT GG) and primer R (CTA GCC AAT AAT CGC GAT GC), followed by sequencing. Amplifications were performed using Hot-StarTaq DNA polymerase (Qiagen, Hilden, Germany). PCR conditions were as follows: (i) 15 min at 95°C and (ii) 35 cycles, with 1 cycle consisting of 1 min at 94°C, 1 min at 64°C, 1 min at 72°C, and (iii) 10 min at 72°C. The presence of aac(6')-Ib-cr was determined by PCR followed by digestion with BtsCI (New England BioLabs, Beverly, MA) (14).

Transconjugation experiments were performed using the filter mating method with E. coli strain HB101 as a recipient. Transconjugants were selected on Muller-Hinton plates containing 0.5 mg/ml streptomycin and 2 µg/ml imipenem or 0.5 mg/ml streptomycin and 100 µg/ml ampicillin.

Plasmid DNA from clinical strains and their transformants were isolated using NucleoBond PC 100 midi kit (Macherey-Nagel, Germany). Transformation experiments were carried out by electroporation (electroporator 2510; Eppendorf, Hamburg, Germany) into an E. coli strain GeneHogs (recA1 mutant) (Invitrogen, Carlsbad, CA). Transformants were selected on LB agar plates containing 100 µg/ml ampicillin. Transformed colonies were screened by PCR for the presence of blaKPC, blaSHV, and qnr genes. Plasmid size was estimated using BAC-Tracker supercoiled DNA ladder (Epicenter Biotechnologies, Madison, WI). Further size estimation of the transforming plasmids was performed by digestion with S1 nuclease, followed by PFGE. DNA was prepared as described previously (12, 22) and digested with S1 nuclease (Promega, Madison, WI) (1). Electrophoresis was carried out as described previously (8). Lambda ladder PFG marker (New England Biolabs) was used as a molecular size marker. For Southern blot analysis, plasmid DNA from transformants that was digested with EcoRI (New England Biolabs) or not digested was electrophoresed, transferred to a Hybond N+ membrane (Amersham Biosciences, Buckinghamshire, United Kingdom), and cross-linked with UV light. A 469-bp PCR amplicon (nucleotides 138 to 607) was used to generate a probe for qnrB. The complete nucleotide sequence of blaKPC-2 (892 bp) was used as a probe for KPC-2. Labeling of probes was performed using random primer DNA labeling mixture (Biological Industries, Beit Haemek, Israel).

The 16 studied carbapenem-resistant E. cloacae isolates belonged to three different genetic clones, clones A, B, and C according to the criteria established by Tenover et al. (24) (Table 1). All isolates were resistant to aztreonam and gentamicin. Fifteen isolates were resistant to ceftazidime, and isolate 151 had a MIC for ceftazidime of 16 µg/ml. Resistance to cefepime varied (data not shown). All isolates were susceptible to quinolones and amikacin, except for isolate 837 that had a MIC for amikacin of 32 µg/ml and carried aac(6')-Ib.


View this table:
[in this window]
[in a new window]

  		TABLE 1. PFGE genetic clones, resistance genes, and antibiotic susceptibilities of E. cloacae clinical isolates and their transformants

Molecular analysis of antibiotic resistance genes revealed the presence of blaKPC-2 in all isolates, and 14 of these isolates also carried the qnrB gene. The two isolates negative for qnrB (isolates 140 and 354) had the lowest MICs for CIP and LEV (Table 1). Fifteen of the isolates also possessed blaSHV-12. The complete amplified qnrB gene was sequenced and proved to be qnrB2. Screening for the presence of aac(6')-Ib-cr, encoding the modified aminoglycoside acetyltransferase, was positive in one isolate (isolate 293) that had the highest MIC for CIP (1.5 µg/ml [Table 1]). The plasmid patterns of all strains belonging to genetic clones A and B were similar and revealed several plasmids ranging in size from ca. 8 kb to larger than 164 kb. The genetic clone C isolate contained two additional plasmids of about 28 and 38 kb (data not shown). Attempts to transfer qnrB2- and blaKPC-2-carrying plasmids from eight isolates (belonging to clones A, B, and C) to E. coli strain HB101 failed, suggesting that these plasmids are not conjugable.

Transformation experiments succeeded with genetic clones A and B and failed with clone C. Transformants T-622, T-625, and T-781 were further characterized (Table 1). PCR analysis of this plasmid revealed the presence of qnrB2 accompanied by blaKPC-2 and blaSHV-12. All transformants showed increased MICs to quinolones upon acquisition of this plasmid; transformants T-622 and T-781 exhibited threefold- and twofold-higher MICs for CIP and LEV, respectively, whereas T-625 exhibited sixfold- and fourfold-higher MICs for CIP and LEV, respectively (Table 1). MICs of carbapenems increased in all transformants, and resistance to gentamicin, ceftazidime, piperacillin, and piperacillin-tazobactam was transferred in all of the transformants (Table 1). All transformed strains contained a single plasmid (Fig. 1A and B, panel I). Plasmids from transformants T-622 and T-781 had similar sizes and migrated with an apparent size of lambda bands of 291 to 339.5 kbp. Plasmid from transformant T-625 migrated in the same size range but seemed to be larger (Fig. 1A, lane 2). These findings revealed that the two E. cloacae isolates that belonged to clones A and B possessed plasmids of similar size, whereas the two clone A isolates (622 and 625) possessed different-size plasmids. To further confirm the coexistence of blaKPC-2 and qnrB2 on the same plasmid and to examine the similarity between the plasmids carrying them, Southern blot analysis was performed. Hybridization of uncut plasmids from transformed strains T-622, T-625, and T-781 confirmed the presence of blaKPC-2 and qnrB2 on the transforming plasmids (Fig. 1B, panels II and III). The hybridization patterns of transformants digested with EcoRI and using qnrB2 or blaKPC-2 as a probe were similar (Fig. 1C, panels I and II).


Figure 1
View larger version (51K):
[in this window]
[in a new window]

  		FIG. 1. (A) PFGE of transformants T-622 (lane 1), T-625 (lane 2), and T-781 (lane 3) digested with S1 nuclease. Transformants T-622 and T-625 originated from E. cloacae clone A isolates, and T-781 originated from a clone B isolate. Lane M, lambda ladder PFG marker (New England Biolabs). Plasmid DNAs are indicated by white arrows. (B) Panel I shows electrophoresis of the plasmids that transformed the bacterial strain (lanes 1 to 3). Plasmid DNA (p) and chromosomal DNA (c) are indicated by arrows. Lane M, BAC-Tracker supercoiled DNA ladder (Epicenter). Panels II and III show the results of Southern blot analysis of undigested transforming plasmids hybridized with a 469-bp fragment of qnrB2 (II) and with blaKPC-2 (KPC-2) (III). The positions of molecular size standards are indicated to the left of the gels in panels A and B. (C) Panels I and II show plasmid DNA digested with EcoRI and hybridized with qnrB2 and blaKPC-2 (KPC-2). The positions of molecular size markers (1-kb DNA ladder; Fermentas)are indicated to the left of the gel.

All blaKPC-2 carbapenem-resistant E. cloacae strains included in this study were susceptible to quinolones. Fourteen out of 16 strains were found to carry the qnrB2 gene, and one strain also carried aac(6')-Ib-cr. This isolate had a higher level of resistance to CIP than the isolates carrying only qnrB2, similar to a previous report on qnrA (18). Transformations studied by PCR and Southern blot analysis proved the coexistence of qnrB2 and blaKPC-2 on the same plasmid.

qnr determinants alone may not confer resistance to quinolones (10), but they can supplement other quinolone resistance mechanisms (11, 16). In our study, 14 isolates carrying qnrB2 were classified as ciprofloxacin susceptible by CLSI criteria. Thus, treatment with a fluoroquinolone might easily select for resistant strains. Our finding that 14 of 16 carbapenem-resistant E. cloacae strains, isolated between 2004 and 2006, carried qnrB2 is similar to a previous report from Israel (23); qnrA was more prevalent until 2001, but since then, qnrB has predominated (23).

qnr determinants are usually associated with additional antimicrobial-resistant determinants (6, 13, 23, 25). This is the first report of the association of qnrB2 with blaKPC-2 carbapenemase on a single plasmid in two genetically unrelated clones of E. cloacae. In addition to the potential of these strains to develop high-level resistance to quinolones, the coexistence of multiple resistant genes on the same plasmid, which may confer resistance to both carbapenems and quinolones, poses a serious epidemiological, clinical, and public health threat.


arrow
ACKNOWLEDGMENTS
 
This work was supported by the Research Fund of Chief Scientist Office, Ministry of Health (Jerusalem, Israel).

We are grateful to George A. Jacoby for donating the qnrA, qnrB, and qnrS control strains.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Division of Epidemiology, Tel Aviv Sourasky Medical Center, 6 Weizmann St., Tel Aviv 64239, Israel. Phone: 972 3 692 5644. Fax: 972 3 697 4966. E-mail: yehudac{at}tasmc.health.gov.il Back

{triangledown} Published ahead of print on 2 June 2008. Back


arrow
REFERENCES
 
    1
  1. Barton, B. M., G. P. Harding, and A. J. Zuccarelli. 1995. A general method for detecting and sizing large plasmids. Anal. Biochem. 226:235-240.[CrossRef][Medline]
    2. 2
  2. Baucheron, S., H. Imberechts, E. Chaslus-Dancla, and A. Cloeckaert. 2002. The AcrB multidrug transporter plays a major role in high-level fluoroquinolone resistance in Salmonella enterica serovar Typhimurium phage type DT204. Microb. Drug Resist. 8:281-289.[CrossRef][Medline]
    3. 3
  3. Bratu, S., P. Tolaney, U. Karumudi, J. Quale, M. Mooty, S. Nichani, and D. Landman. 2005. Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents. J. Antimicrob. Chemother. 56:128-132.[Abstract/Free Full Text]
    4. 4
  4. Cattoir, V., L. Poirel, V. Rotimi, C.-J. Soussy, and P. Nordmann. 2007. Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J. Antimicrob. Chemother. 60:394-397.[Abstract/Free Full Text]
    5. 5
  5. Hata, M., M. Suzuki, M. Matsumoto, M. Takahashi, K. Sato, S. Ibe, and K. Sakae. 2005. Cloning of a novel gene for quinolone resistance from a transferable plasmid in Shigella flexneri 2b. Antimicrob. Agents Chemother. 49:801-803.[Abstract/Free Full Text]
    6. 6
  6. Jacoby, G. A., N. Chow, and K. B. Waites. 2003. Prevalence of plasmid-mediated quinolone resistance. Antimicrob. Agents Chemother. 47:559-562.[Abstract/Free Full Text]
    7. 7
  7. Jacoby, G. A., K. E. Walsh, D. M. Mills, V. J. Walker, H. Oh, A. Robicsek, and D. C. Hooper. 2006. qnrB, another plasmid-mediated gene for quinolone resistance. Antimicrob. Agents Chemother. 50:1178-1182.[Abstract/Free Full Text]
    8. 8
  8. Li, L., and C. K. Lim. 2000. A novel large plasmid carrying multiple β-lactam resistance genes isolated from a Klebsiella pneumoniae strain. J. Appl. Microbiol. 88:1038-1048.[CrossRef][Medline]
    9. 9
  9. Marchaim, D., S. Navon-Venezia, M. J. Schwaber, and Y. Carmeli. 2008. Imipenem-resistant Enterobacter species isolation: the emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes. Antimicrob. Agents Chemother. 52:1413-1418.[Abstract/Free Full Text]
    10. 10
  10. Martinez-Martinez, L., A. Pascual, and G. A. Jacoby. 1998. Quinolone resistance from a transferable plasmid. Lancet 351:797-799.[CrossRef][Medline]
    11. 11
  11. Martínez-Martínez, L., A. Pascual, I. García, J. Tran, and G. A. Jacoby. 2003. Interaction of plasmid and host quinolone resistance. J. Antimicrob. Chemother. 51:1037-1039.[Free Full Text]
    12. 12
  12. Noller, A. C., M. C. McEllistrem, O. C. Stine, J. G. Morris, Jr., D. J. Boxrud, B. Dixon, and L. H. Harrison. 2003. Multilocus sequence typing reveals a lack of diversity among Escherichia coli O157:H7 isolates that are distinct by pulsed-field gel electrophoresis. J. Clin. Microbiol. 41:675-679.[Abstract/Free Full Text]
    13. 13
  13. Nordmann, P., and L. Poirel. 2005. Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae. J. Antimicrob. Chemother. 56:463-469.[Abstract/Free Full Text]
    14. 14
  14. Park, C. H., A. Robicsek, G. A., Jacoby, D. Sahm, and D. C. Hooper. 2006. Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob. Agents Chemother. 50:3953-3955.[Abstract/Free Full Text]
    15. 15
  15. Périchon, B., P. Courvalin, and M. Galimand. 2007. Transferable resistance to aminiglycosides by methyation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli. Antimicrob. Agents Chemother. 51:2464-2469.[Abstract/Free Full Text]
    16. 16
  16. Poirel, L., J. D. D. Pitout, L. Calvo, J.-M. Rodriguez-Martinez, D. Church, and P. Nordmann. 2006. In vivo selection of fluoroquinolone-resistant Escherichia coli isolates expressing plasmid-mediated quinolone resistance and expanded-spectrum β-lactamase. Antimicrob. Agents Chemother. 50:1525-1527.[Abstract/Free Full Text]
    17. 17
  17. Robicsek, A., G. A. Jacoby, and D. C. Hooper. 2006. The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect. Dis. 6:629-640.[CrossRef][Medline]
    18. 18
  18. Robicsek, A., J. Strahilevitz, G. A. Jacoby, M. Macielag, D. Abbanat, C. H. Park, K. Bush, and D. C. Hooper. 2006. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat. Med. 12:83-88.[CrossRef][Medline]
    19. 19
  19. Robicsek, A., J. Strahilevitz, D. F. Sahm, G. A. Jacoby, and D. C. Hooper. 2006. qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob. Agents Chemother. 50:2872-2874.[Abstract/Free Full Text]
    20. 20
  20. Rodríguez-Martínez, J. M., C. Velasco, I. Garcia, M. E. Cano, L. Martínez-Martínez, and A. Pascual. 2007. Mutant prevention concentrations of fluoroquinolones for Enterobacteriaceae expressing the plasmid-carried quinolone resistance determinant qnrA1. Antimicrob. Agents Chemother. 51:2236-2239.[Abstract/Free Full Text]
    21. 21
  21. Ruiz, J. 2003. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J. Antimicrob. Chemother. 51:1109-1117.[Abstract/Free Full Text]
    22. 22
  22. Schlesinger, J., S. Navon-Venezia, I. Chmelnitsky, O. Hammer-Münz, A. Leavitt, H. S. Gold, M. J. Schwaber, and Y. Carmeli. 2005. Extended-spectrum beta-lactamases among Enterobacter isolates obtained in Tel-Aviv, Israel. Antimicrob. Agents Chemother. 49:1150-1156.[Abstract/Free Full Text]
    23. 23
  23. Strahilevitz, J., D. Engelstein, A. Adler, V. Temper, A. E. Moses, C. Block, and A. Robicsek. 2007. Changes in qnr prevalence and fluoroquinolone resistance in clinical isolates of Klebsiella pneumoniae and Enterobacter spp. collected from 1990 to 2005. Antimicrob. Agents Chemother. 51:3001-3003.[Abstract/Free Full Text]
    24. 24
  24. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.[Free Full Text]
    25. 25
  25. Wu, J.-J., W.-C. Ko, S.-H. Tsai, and J.-J. Yan. 2007. Prevalence of plasmid-mediated quinolone resistance determinants QnrA, QnrB, and QnrS among clinical isolates of Enterobacter cloacae in a Taiwanese hospital. Antimicrob. Agents Chemother. 51:1223-1227.[Abstract/Free Full Text]
    26. 26
  26. Yamane, K., J.-I. Wachino, S. Suzuki, K. Kimura, N. Shibata, H. Kato, K. Shibayama, T. Konda, and Y. Arakawa. 2007. New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate. Antimicrob. Agents Chemother. 51:3354-3360.[Abstract/Free Full Text]

Antimicrobial Agents and Chemotherapy, August 2008, p. 2962-2965, Vol. 52, No. 8
0066-4804/08/$08.00+0     doi:10.1128/AAC.01341-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Strahilevitz, J., Jacoby, G. A., Hooper, D. C., Robicsek, A. (2009). Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat. Clin. Microbiol. Rev. 22: 664-689 [Abstract] [Full Text]  
  • Chmelnitsky, I., Hermesh, O., Navon-Venezia, S., Strahilevitz, J., Carmeli, Y. (2009). Detection of aac(6')-Ib-cr in KPC-producing Klebsiella pneumoniae isolates from Tel Aviv, Israel. J Antimicrob Chemother 64: 718-722 [Abstract] [Full Text]  
  • Govender, N., Smith, A. M., Karstaedt, A. S., Keddy, K. H., for the Group for Enteric, Respiratory and Meninge, (2009). Plasmid-mediated quinolone resistance in Salmonella from South Africa. J Med Microbiol 58: 1393-1394 [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chmelnitsky, I.
Right arrow Articles by Carmeli, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chmelnitsky, I.
Right arrow Articles by Carmeli, Y.

Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»